company background image
NUS logo

Nu Skin Enterprises NYSE:NUS Voorraadrapport

Laatste prijs

US$7.59

Marktkapitalisatie

US$377.3m

7D

1.5%

1Y

-55.2%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

Nu Skin Enterprises, Inc.

NYSE:NUS Voorraadrapport

Marktkapitalisatie: US$377.3m

NUS Overzicht aandelen

Nu Skin Enterprises, Inc. houdt zich samen met haar dochterondernemingen wereldwijd bezig met de ontwikkeling en distributie van verschillende schoonheids- en welzijnsproducten. Meer informatie

Nu Skin Enterprises, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Nu Skin Enterprises
Historische aandelenkoersen
Huidige aandelenkoersUS$7.59
52 Week HoogtepuntUS$20.75
52 Week LaagUS$5.95
Bèta1.13
11 maand verandering23.21%
3 maanden verandering-20.69%
1 Jaar Verandering-55.25%
33 jaar verandering-83.53%
5 jaar verandering-80.55%
Verandering sinds IPO-73.60%

Recent nieuws en updates

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

Recent updates

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31
Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22
We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26
Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18
Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19
Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

Rendement voor aandeelhouders

NUSUS Personal ProductsUS Markt
7D1.5%-0.2%-1.2%
1Y-55.2%-13.3%30.4%

Rendement versus industrie: NUS presteerde slechter dan de US Personal Products -sector, die het afgelopen jaar een rendement van -13.3 % opleverde.

Rendement versus markt: NUS presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.4 % opleverde.

Prijsvolatiliteit

Is NUS's price volatile compared to industry and market?
NUS volatility
NUS Average Weekly Movement7.8%
Personal Products Industry Average Movement8.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: NUS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van NUS is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19843,700Ryan Napierskiwww.nuskin.com

Nu Skin Enterprises, Inc. houdt zich samen met haar dochterondernemingen bezig met de ontwikkeling en distributie van verschillende schoonheids- en welzijnsproducten wereldwijd. Het bedrijf biedt huidverzorgingsproducten, cosmetica en andere persoonlijke verzorgingsproducten, waaronder ageLOC LumiSpa en ageLOC LumiSpa iO; en nutricentials huidverzorgingsproducten. Het bedrijf levert ook wellnessproducten, zoals LifePak voedingssupplementen, ageLOC TR90 gewichtsbeheersingssysteem en Beauty Focus Collagen+.

Nu Skin Enterprises, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Nu Skin Enterprises zich tot de beurswaarde?
NUS fundamentele statistieken
MarktkapitalisatieUS$377.31m
Inkomsten(TTM)-US$103.21m
Inkomsten(TTM)US$1.78b

0.2x

P/S-verhouding

-3.7x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NUS resultatenrekening (TTM)
InkomstenUS$1.78b
Kosten van inkomstenUS$454.34m
BrutowinstUS$1.32b
Overige uitgavenUS$1.42b
Inkomsten-US$103.21m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-2.08
Brutomarge74.41%
Nettowinstmarge-5.81%
Schuld/Eigen Vermogen Verhouding61.3%

Hoe presteerde NUS op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.2%

Huidig dividendrendement

-27%

Uitbetalingsratio

Betaalt NUS een betrouwbaar dividend?

Zie NUS dividendgeschiedenis en benchmarks
Wanneer moet je NUS kopen om een aanstaand dividend te ontvangen?
Nu Skin Enterprises dividenddata
Ex Dividend DatumNov 29 2024
Betaaldatum dividendDec 11 2024
Dagen tot Ex-dividend8 days
Dagen tot dividendbetaaldatum20 days

Betaalt NUS een betrouwbaar dividend?

Zie NUS dividendgeschiedenis en benchmarks